The slip
PARKINSON RECEIPTno. 15396
30 Oct 2026, 18:42 UTColigodendrocytes, braak
predictionTMEM144 in oligodendrocytes tracks Braak Lewy-body stage
registered25c0d7e2640b7614
discovery+0.66 p=0.053 n=9
replication+0.02 p=0.964 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.66, p 0.053)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf2de159ef5d6430763b3a006…
follows 45c5e00b41a9…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15396: TMEM144 in oligodendrocytes, braak
- power
- full sample +0.29 (p 0.250, n 18), 95% CI -0.21 to +0.66. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.33 (p 0.185, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.26 (p 0.302, n 18). could be the mix.
- skeptic
- leave-one-out range +0.19 to +0.45, sign flips 0; without severely affected donors +0.29 (p 0.250, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TMEM144 in oligodendrocytes.
case closed: nothing better to follow up.